200 related articles for article (PubMed ID: 12857790)
1. Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications.
Norris EH; Giasson BI; Ischiropoulos H; Lee VM
J Biol Chem; 2003 Jul; 278(29):27230-40. PubMed ID: 12857790
[TBL] [Abstract][Full Text] [Related]
2. Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies.
Souza JM; Giasson BI; Chen Q; Lee VM; Ischiropoulos H
J Biol Chem; 2000 Jun; 275(24):18344-9. PubMed ID: 10747881
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine 125 of alpha-synuclein plays a critical role for dimerization following nitrative stress.
Takahashi T; Yamashita H; Nakamura T; Nagano Y; Nakamura S
Brain Res; 2002 May; 938(1-2):73-80. PubMed ID: 12031537
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine-to-cysteine modification of human alpha-synuclein enhances protein aggregation and cellular toxicity.
Zhou W; Freed CR
J Biol Chem; 2004 Mar; 279(11):10128-35. PubMed ID: 14699135
[TBL] [Abstract][Full Text] [Related]
5. Oxidative modifications of alpha-synuclein.
Ischiropoulos H
Ann N Y Acad Sci; 2003 Jun; 991():93-100. PubMed ID: 12846977
[TBL] [Abstract][Full Text] [Related]
6. Induction of alpha-synuclein aggregation by intracellular nitrative insult.
Paxinou E; Chen Q; Weisse M; Giasson BI; Norris EH; Rueter SM; Trojanowski JQ; Lee VM; Ischiropoulos H
J Neurosci; 2001 Oct; 21(20):8053-61. PubMed ID: 11588178
[TBL] [Abstract][Full Text] [Related]
7. Role of oxidative damage in protein aggregation associated with Parkinson's disease and related disorders.
Norris EH; Giasson BI
Antioxid Redox Signal; 2005; 7(5-6):672-84. PubMed ID: 15890012
[TBL] [Abstract][Full Text] [Related]
8. Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation.
Hodara R; Norris EH; Giasson BI; Mishizen-Eberz AJ; Lynch DR; Lee VM; Ischiropoulos H
J Biol Chem; 2004 Nov; 279(46):47746-53. PubMed ID: 15364911
[TBL] [Abstract][Full Text] [Related]
9. Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments.
Cole NB; Murphy DD; Lebowitz J; Di Noto L; Levine RL; Nussbaum RL
J Biol Chem; 2005 Mar; 280(10):9678-90. PubMed ID: 15615715
[TBL] [Abstract][Full Text] [Related]
10. Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis.
Krishnan S; Chi EY; Wood SJ; Kendrick BS; Li C; Garzon-Rodriguez W; Wypych J; Randolph TW; Narhi LO; Biere AL; Citron M; Carpenter JF
Biochemistry; 2003 Jan; 42(3):829-37. PubMed ID: 12534296
[TBL] [Abstract][Full Text] [Related]
11. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.
Mishizen-Eberz AJ; Norris EH; Giasson BI; Hodara R; Ischiropoulos H; Lee VM; Trojanowski JQ; Lynch DR
Biochemistry; 2005 May; 44(21):7818-29. PubMed ID: 15909996
[TBL] [Abstract][Full Text] [Related]
12. Characterization of oligomeric intermediates in alpha-synuclein fibrillation: FRET studies of Y125W/Y133F/Y136F alpha-synuclein.
Kaylor J; Bodner N; Edridge S; Yamin G; Hong DP; Fink AL
J Mol Biol; 2005 Oct; 353(2):357-72. PubMed ID: 16171820
[TBL] [Abstract][Full Text] [Related]
13. alpha-Synuclein-synaptosomal membrane interactions: implications for fibrillogenesis.
Jo E; Darabie AA; Han K; Tandon A; Fraser PE; McLaurin J
Eur J Biochem; 2004 Aug; 271(15):3180-9. PubMed ID: 15265037
[TBL] [Abstract][Full Text] [Related]
14. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
Giasson BI; Duda JE; Murray IV; Chen Q; Souza JM; Hurtig HI; Ischiropoulos H; Trojanowski JQ; Lee VM
Science; 2000 Nov; 290(5493):985-9. PubMed ID: 11062131
[TBL] [Abstract][Full Text] [Related]
15. Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein.
Cole NB; Murphy DD; Grider T; Rueter S; Brasaemle D; Nussbaum RL
J Biol Chem; 2002 Feb; 277(8):6344-52. PubMed ID: 11744721
[TBL] [Abstract][Full Text] [Related]
16. Site-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: implications for Alzheimer's disease.
Reynolds MR; Berry RW; Binder LI
Biochemistry; 2005 Feb; 44(5):1690-700. PubMed ID: 15683253
[TBL] [Abstract][Full Text] [Related]
17. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies.
Duda JE; Giasson BI; Chen Q; Gur TL; Hurtig HI; Stern MB; Gollomp SM; Ischiropoulos H; Lee VM; Trojanowski JQ
Am J Pathol; 2000 Nov; 157(5):1439-45. PubMed ID: 11073803
[TBL] [Abstract][Full Text] [Related]
18. Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Przedborski S; Chen Q; Vila M; Giasson BI; Djaldatti R; Vukosavic S; Souza JM; Jackson-Lewis V; Lee VM; Ischiropoulos H
J Neurochem; 2001 Jan; 76(2):637-40. PubMed ID: 11208927
[TBL] [Abstract][Full Text] [Related]
19. Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins.
Uversky VN; Li J; Souillac P; Millett IS; Doniach S; Jakes R; Goedert M; Fink AL
J Biol Chem; 2002 Apr; 277(14):11970-8. PubMed ID: 11812782
[TBL] [Abstract][Full Text] [Related]
20. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.
Giasson BI; Duda JE; Quinn SM; Zhang B; Trojanowski JQ; Lee VM
Neuron; 2002 May; 34(4):521-33. PubMed ID: 12062037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
